🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the immunogenicity of na...
Status
Terminated
Location
Research Site
Start Date
2014-12-01
Trial ID
NCT02142192
Treatments Being Tested
This is a non-randomized phase II trial of denosumab at 120 mg subcutaneous...
Status
Completed
Location
Stony Brook University Cancer Center
Start Date
2015-11
Trial ID
NCT02613416
Treatments Being Tested
This study is a multi-center, randomized, double-blind, placebo-controlled ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-13
Trial ID
NCT06547333
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Start Date
2024-09-23
Trial ID
NCT06554847
Treatments Being Tested
This is a Phase I/II study designed to evaluate the safety, tolerability, P...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-02-05
Trial ID
NCT07375758
Treatments Being Tested
This is a Phase II, randomized, double-blind, placebo-controlled, parallel-...
Status
Completed
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01225393
Treatments Being Tested
This study is a randomized, double-blind and placebo-controlled trial with ...
Status
Completed
Location
Peking University People's Hospital
Start Date
2015-05
Trial ID
NCT02460393
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Completed
Location
Beijing Tong-Ren hospital
Start Date
2023-08-10
Trial ID
NCT05908032
This is a 128-week open-label study to assess the long-term safety and tole...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-09-30
Trial ID
NCT04084314
Treatments Being Tested
This is a 2-cohort (observational and treatment cohort) extension study for...
Status
Terminated
Location
Site Number - 1520
Start Date
2022-11-06
Trial ID
NCT05517447
Treatments Being Tested